New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Go back to New Long-Term Data for UPLIZNA® (inebilizumab-cdon) in People Living with Neuromyelitis Optica Spectrum Disorder (NMOSD)| National Health Partners, Inc. (NYSE: HPR) | Delayed: 4.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.73 | 52 Week High | $0.28 | |||
| Open | $3.62 | 52 Week Low | $0.25 | |||
| Day High | $4.73 | P/E | N/A | |||
| Day Low | $4.73 | EPS | $-0.23 | |||
| Volume | 3,248 | |||||
| HORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $116.30 | 52 Week High | $23.44 | |||
| Open | $116.30 | 52 Week Low | $13.06 | |||
| Day High | $116.30 | P/E | N/A | |||
| Day Low | $116.30 | EPS | $-0.96 | |||
| Volume | 1 | |||||
